Gimeno, Esteban J.
Bøgelund, Mette
Larsen, Sara
Okkels, Anna
Reitzel, Signe B.
Ren, Hongye
Orozco-Beltran, Domingo
Article History
Received: 12 December 2023
Accepted: 27 February 2024
First Online: 23 March 2024
Declarations
:
: Hongye Ren and Sara Larsen are employees of Novo Nordisk. Mette Bøgelund, Signe Baattrup Reitzel and Anna Okkels are employees of EY, which is a paid vendor of Novo Nordisk. After completion of the manuscript, Signe Baattrup Reitzel has changed affiliation to Medical Science, Novo Nordisk Foundation. Esteban Jodar reports consultancy services and speaker fees from Audium, Amgen, AstraZeneca, Boehringer, FAES, Eli Lilly, MSD, Novo Nordisk, UCB and ZP pharmaceutica. Domingo Orozco-Beltrán has provided consultancy services to MSD and Novartis and has lectured for Novartis, Mundipharma, Novo Nordisk, Sanofi Aventis and Eli Lilly.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.